| dc.contributor.author |
Niriella, M.A. |
|
| dc.contributor.author |
Dassanayake, U. |
|
| dc.contributor.author |
de Silva, H.J. |
|
| dc.date.accessioned |
2022-09-29T04:40:23Z |
|
| dc.date.available |
2022-09-29T04:40:23Z |
|
| dc.date.issued |
2023 |
|
| dc.identifier.citation |
Scandinavian Journal of Gastroenterology. 2023; 58(3):223-226.[Epub 2022 Sep 16] |
en_US |
| dc.identifier.issn |
0036-5521 |
|
| dc.identifier.uri |
http://repository.kln.ac.lk/handle/123456789/25272 |
|
| dc.description |
Indexed in MEDLINE & SCOPUS |
en_US |
| dc.description.abstract |
Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease. NAFLD is estimated to affect 25% of the global population. Therefore, it is widely encountered in primary care. A proportion of patients with NAFLD need a specialist referral, evaluation and follow-up.There have been many updated guidelines on the management of NAFLD in the past few years. Given the burden of NAFLD in the community and its cardiovascular and liver-related adverse outcomes, knowledge of evidence-based standards of care for these patients is essential for any practitioner managing patients with NAFLD. As an asymptomatic disease in the early stages, NAFLD can lead to many mistakes in its management.We aim to highlight some common mistakes in managing NAFLD and attempt to provide evidence-based recommendations. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Informa Health Care |
en_US |
| dc.subject |
Fatty Liver |
en_US |
| dc.subject |
Non-alcoholic Fatty Liver Disease |
en_US |
| dc.subject |
Non-alcoholic Fatty Liver Disease-therapy |
en_US |
| dc.title |
'Mistakes in managing non-alcoholic fatty liver disease and how to avoid them' |
en_US |
| dc.type |
Article |
en_US |